Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery

Author(s): Ariane Sternberg, Dwight L. McKee, Cord Naujokat*

Journal Name: Current Topics in Medicinal Chemistry

Volume 20 , Issue 16 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Like other human pathogenic viruses, coronavirus SARS-CoV-2 employs sophisticated macromolecular machines for viral host cell entry, genome replication and protein processing. Such machinery encompasses SARS-CoV-2 envelope spike (S) glycoprotein required for host cell entry by binding to the ACE2 receptor, viral RNA-dependent RNA polymerase (RdRp) and 3-chymotrypsin-like main protease (3Clpro/Mpro). Under the pressure of the accelerating COVID-19 pandemic caused by the outbreak of SARS-CoV-2 in Wuhan, China in December 2019, novel and repurposed drugs were recently designed and identified for targeting the SARS-CoV-2 reproduction machinery, with the aim to limit the spread of SARS-CoV-2 and morbidity and mortality due to the COVID-19 pandemic.

Keywords: Coronavirus SARS-CoV-2, COVID-19, S protein, RNA polymerase, 3Clpro, Camostat, Remdesivir, α-Ketoamides.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [1423 - 1433]
Pages: 11
DOI: 10.2174/1568026620999200517043137

Article Metrics

PDF: 76